Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 25, 1999

View Archived Issues

Corvas continues development progress during third quarter

AHP updates investors and analysts on R&D progress

Idec completes patient enrollment in two pivotal studies during third quarter

Review of Hectorol Injection NDA back on course

Potassium channel activator SKP-450 has potent antiulcer effects in rat models

Three-year subdermal contraceptive implant marketed in the U.K.

Sanofi-Synthelabo's platinum complex launched in second European market

Wound-healing agent reaches the market in U.K.

Creative BioMolecules funnels resources towards stroke and renal disease therapy

Polyethoxylated retinamides superior to known retinoic acid derivatives for skin aging

Interim phase I/II results presented for Transgene's TG-1021

Preclinical results indicate that nefiracetam may have anticonvulsant effects

News from AAO/PAAO joint meeting: droperidol may be indicated for glaucoma

Cancer immunotherapy method available for licensing from NIH

Alphagan safely and effectively lowers IOP in glaucoma patients

Specific FKBP-12 rotamase inhibitors useful for neurodegenerative disorders

Nonpeptide integrin antagonists from DuPont and use for inhibiting cell adhesion

AHP's new beta3-adrenoceptor agonists presented in patent literature

HepaVec and CSIRO sign option agreement for ovine viral vector technology

New anticoagulants in the pipeline at DuPont

U. of Minnesota designs anticancer, antiviral phosphoramidated nucleosides

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...